Malaria caused by P. falciparum continues to be a global problem with devastating consequences. A greater understanding of the immunologic and parasitologic factors associated with infection and disease is badly needed, and will accelerate the development of highly protective vaccines for both mothers and children. Pregnancy malaria is associated with low birth weight, maternal anemia, and gestational hypertension, and both inflammation and the fetal response to infection may contribute to these poor outcomes. Childhood malaria is a major cause of mortality, and we have found that risk of childhood malaria is related to in utero exposure to pregnancy malaria, as well as other host factors like iron status and constitutive cytokine levels. Pregnancy malaria is caused by a distinct parasite binding phenotype, and as our primary hypothesis in this study we speculate that severe childhood malaria parasites may also have distinct features. A longitudinal cohort study is being conducted in Ouelessebougou, Mali, an area of intense seasonal transmission. Up to 2000 pregnant women and their infants and 2000 children ages 0-3 years will be enrolled and the children followed to age 5 years, with clinical evaluation and periodic venous and peripheral blood samples being obtained. In addition, 2000 febrile children up to age 10 years will be enrolled at the Ouelessebougou district hospital or the Gabriel Toure Pediatric Hospital in Bamako, Mali, with acute and convalescent samples being obtained. Clinical, parasitologic and host response (including immunologic) endpoints will be analyzed using appropriate statistical methods, including possible confounders, to determine factors associated with infection and disease in pregnant women and young children. In order to address the associations of pregnancy malaria and preeclampsia, diastolic blood pressure, hypertension, sFlt1 elevations, and urine proteins will be considered as study outcomes. The primary analysis will be the change in diastolic BP over a 1 month period. Women will have BP measured monthly during pregnancy. The interest is if the women who experience malaria have a different change in diastolic BP 1 month after the malaria episode compared to gestationally matched controls. Similarly, associations of pregnancy malaria to stillbirth and preterm delivery will be analyzed for temporal patterns. To date we have enrolled 1500 women in the study who we are monitoring for malaria, blood pressure, urinary protein measurements, and pregnancy outcomes. 1000 women have given birth and their newborns enrolled in the study, and the children are similarly being followed to document episodes of malaria infection, disease, and severe disease, thereby offering an opportunity to identify the parasite and host factors that contirbute to the risks of infection and disease. Parallel to the field studies being conducted in Mali, scientists at the Twinbrook labs have focused on establishing animal models of malaria pathogenesis and immunity, and interrogating these models to gain basic insights into malaria pathogenesis and immunity. These insights will generate hypotheses for testing in the ongoing field studies in Mali. The animal models being developed include models of pregnancy malaria, severe malaria, liver stage malaria, chronic blood stage malaria, and sexual stage malaria. During the past year, we have established a rhesus model of severe malaria anemia, a rodent model of chronic parasitemia, a rodent model of recrudescent malaria during pregnancy, and finally have established a breeding colony of African thicket rats which are the natural host of the rodent malaria parasites. The African thicket rats will be studied to assess whether the course of malaria in these hosts has more similarities to what is seen in human malaria.

Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Zip Code
Sharma, Ankur; Conteh, Solomon; Langhorne, Jean et al. (2016) Heterologous Infection of Pregnant Mice Induces Low Birth Weight and Modifies Offspring Susceptibility to Malaria. PLoS One 11:e0160120
Doritchamou, Justin Yai Alamou; Herrera, Raul; Aebig, Joan A et al. (2016) VAR2CSA Domain-Specific Analysis of Naturally Acquired Functional Antibodies to Plasmodium falciparum Placental Malaria. J Infect Dis 214:577-86
Langhorne, Jean; Duffy, Patrick E (2016) Expanding the antimalarial toolkit: Targeting host-parasite interactions. J Exp Med 213:143-53
Brickley, Elizabeth B; Spottiswoode, Natasha; Kabyemela, Edward et al. (2016) Cord Blood Hepcidin: Cross-Sectional Correlates and Associations with Anemia, Malaria, and Mortality in a Tanzanian Birth Cohort Study. Am J Trop Med Hyg 95:817-826
Harrington, Whitney E; Fried, Michal; Duffy, Patrick E (2016) Defending the Use of Sulfadoxine-Pyrimethamine for Intermittent Preventive Treatment for Malaria in Pregnancy: A Short-Sighted Strategy. J Infect Dis 213:496-7
Gonçalves, Bronner P; Prevots, D Rebecca; Kabyemela, Edward et al. (2016) Preparing for future efficacy trials of severe malaria vaccines. Vaccine 34:1865-7
Lundgren, Ingrid S; Heltshe, Sonya L; Smith, Arnold L et al. (2015) Bacteremia and malaria in Tanzanian children hospitalized for acute febrile illness. J Trop Pediatr 61:81-5
Gadalla, Nahla B; Tavera, Gloria; Mu, Jianbing et al. (2015) Prevalence of Plasmodium falciparum anti-malarial resistance-associated polymorphisms in pfcrt, pfmdr1 and pfnhe1 in Muheza, Tanzania, prior to introduction of artemisinin combination therapy. Malar J 14:129
Brickley, Elizabeth B; Wood, Angela M; Kabyemela, Edward et al. (2015) Fetal origins of malarial disease: cord blood cytokines as risk markers for pediatric severe malarial anemia. J Infect Dis 211:436-44
Gullingsrud, Justin; Milman, Neta; Saveria, Tracy et al. (2015) High-throughput screening platform identifies small molecules that prevent sequestration of Plasmodium falciparum-infected erythrocytes. J Infect Dis 211:1134-43

Showing the most recent 10 out of 37 publications